Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression

Journal of Investigative Dermatology

Volumn 128, Issue 9, 2008, Pages 2325-2333

  Hu, Hsiao Tang ^a   Huang, Yi Hsien ^a   Chang, Yi Ann ^a   Lee, Chien Kuo ^b   Jiang, Meei Jyh ^a   Wu, Li Wha ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; ARGININE; INTERFERON REGULATORY FACTOR 1; PROTEIN TYROSINE KINASE; STAT1 PROTEIN; TRYPTOPHAN;

ADENOVIRUS; AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VEIN MALFORMATION; VIRUS INFECTION;

EID: 49549120217     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.89     Document Type: Article

References (34)

1. Battle TE, Lynch RA, Frank DA (2006) Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res 66:3649-57
2. Carlson TR, Feng Y, Maisonpierre PC, Mrksich M, Morla AO (2001) Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 276:26516-25
3. Cascone I, Napione L, Maniero F, Serini G, Bussolino F (2005) Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol 170:993-1004
4. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V et al. (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-9
5. Davis S, Papadopoulos N, Aldrich TH, Maisonpierre PC, Huang T, Kovac L et al. (2002) Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 10:38-44
6. de Prati AC, Ciampa AR, Cavalieri E, Zaffini R, Darra E, Menegazzi M et al. (2005) STAT1 as a new molecular target of anti-inflammatory treatment. Curr Med Chem 12:1819-28
7. DeBusk LM, Hallahan DE, Lin PC (2004) Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp Cell Res 298:167-77
8. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A et al. (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-909
9. Fiedler U, Augustin HG (2006) Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 27:552-8
10. Fujitani Y, Hibi M, Fukada T, Takahashi-Tezuka M, Yoshida H, Yamaguchi T et al. (1997) An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Oncogene 14:751-61
11. Furuta S, Wang JM, Wei S, Jeng YM, Jiang X, Gu B et al. (2006) Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature. Cancer Cell 10:13-24
12. Galdiero M, Vitiello M, D'Isanto M, Raieta K, Galdiero E (2006) STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6. Cytokine 36:218-28
13. Geva E, Jaffe RB (2000) Role of angiopoietins in reproductive tract angiogenesis. Obstet Gynecol Surv 55:511-9
14. Harfouche R, Gratton JP, Yancopoulos GD, Noseda M, Karsan A, Hussain SN (2003) Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. FASEB J 17:1523-5
15. Hoefen RJ, Berk BC (2002) The role of MAP kinases in endothelial activation. Vascul Pharmacol 38:271-3
16. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B et al. (1994) Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19:222-7
17. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ Res 86:24-9
18. Korpelainen EI, Karkkainen M, Gunji Y, Vikkula M, Alitalo K (1999) Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18:1-8
19. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM et al. (1996) Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 16:369-75
20. Lemieux C, Maliba R, Favier J, Theoret JF, Merhi Y, Sirois MG (2005) Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 105:1523-30
21. Lim CP, Cao X (2006) Structure, function, and regulation of STAT proteins. Mol Biosyst 2:536-50
22. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
23. Morris PN, Dunmore BJ, Tadros A, Marchuk DA, Darland DC, D'Amore PA et al. (2005) Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations. J Mol Med 83:58-63
24. Mulliken JB, Young AE (1988) Vascular Birthmarks. Philadelphia: Saunders, WB
25. Perdiguero E, Ruiz-Bonilla V, Serrano AL, Munoz-Canoves P (2007) Genetic deficiency of p38alpha reveals its critical role in myoblast cell cycle exit: the p38alpha-JNK connection. Cell Cycle 6:1298-303
26. Sato TN, Qin Y, Kozak CA, Audus KL (1993) Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci USA 90:9355-8
27. Silvennoinen O, Schindler C, Schlessinger J, Levy DE (1993) Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 261:1736-9
28. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-80
29. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H et al. (1999) Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96:1904-9
30. Vignais ML, Sadowski HB, Watling D, Rogers NC, Gilman M (1996) Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol 16:1759-69
31. Vikkula M, Boon LM, Carraway KL III, Calvert JT, Diamonti AJ, Goumnerov B et al. (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-90
32. Wen Z, Zhong Z, Darnell JE Jr (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-50
33. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM (1998) Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514-21
34. Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO et al. (2005) Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 112:1971-8